A Spheroid‐Forming Hybrid Gold Nanostructure Platform That Electrochemically Detects Anticancer Effects of Curcumin in a Multicellular Brain Cancer Model

Small ◽  
2020 ◽  
pp. 2002436 ◽  
Author(s):  
Intan Rosalina Suhito ◽  
Novi Angeline ◽  
Kwang‐Ho Lee ◽  
Huijung Kim ◽  
Chun Gwon Park ◽  
...  
Small ◽  
2021 ◽  
Vol 17 (15) ◽  
pp. 2170066
Author(s):  
Intan Rosalina Suhito ◽  
Novi Angeline ◽  
Kwang‐Ho Lee ◽  
Huijung Kim ◽  
Chun Gwon Park ◽  
...  

Neoplasia ◽  
2003 ◽  
Vol 5 (6) ◽  
pp. 546-554 ◽  
Author(s):  
Nicholas A. Bock ◽  
Gelareh Zadeh ◽  
Lori M. Davidson ◽  
Baoping Qian ◽  
John G. Sled ◽  
...  

2020 ◽  
Vol 34 (S1) ◽  
pp. 1-1
Author(s):  
Andrew Deweyert ◽  
Erin Iredale ◽  
Hu Xu ◽  
Eugene Wong ◽  
Susanne Schmid ◽  
...  

2020 ◽  
Vol 34 (12) ◽  
pp. 16464-16475 ◽  
Author(s):  
Mu Seog Choe ◽  
Joong Sun Kim ◽  
Han Cheol Yeo ◽  
Chang Min Bae ◽  
Ho Jae Han ◽  
...  

2021 ◽  
Vol 23 (Supplement_6) ◽  
pp. vi220-vi220
Author(s):  
Luca Tiberi

Abstract Among children/infant brain tumors, Medulloblastoma (MB) is the most common and stands as a cause for a high percentage of morbidity and mortality among patients During the past few years, studies on human MB have uncovered the existence of four major MB groups: WNT, SHH, Group3 and Group4. Patients with Group3 MB currently have the worst outcome among the four groups, and nearly 50% are metastatic at the time of diagnosis. In the last 3 years in our laboratory, we have developed a novel pediatric Medulloblastoma organoid model. We generated human iPSC-derived cancer organoids upon c-MYC/OTX2 and C-MYC/Gfi1 overexpression, mimicking human MB genetic alterations. Furthermore, the use of DNA methylation signature in combination with MB-specific markers analysis indicates that our organoid-based cancer model recapitulates several features of human MB. Now, we are taking advantage of this technology to produce novel brain cancer organoids that we are using to address cancer biology questions.


Biomolecules ◽  
2020 ◽  
Vol 10 (1) ◽  
pp. 161 ◽  
Author(s):  
Terezia Kiskova ◽  
Peter Kubatka ◽  
Dietrich Büsselberg ◽  
Monika Kassayova

Despite intensive research, malignant brain tumors are among the most difficult to treat due to high resistance to conventional therapeutic approaches. High-grade malignant gliomas, including glioblastoma and anaplastic astrocytoma, are among the most devastating and rapidly growing cancers. Despite the ability of standard treatment agents to achieve therapeutic concentrations in the brain, malignant gliomas are often resistant to alkylating agents. Resveratrol is a plant polyphenol occurring in nuts, berries, grapes, and red wine. Resveratrol crosses the blood‒brain barrier and may influence the central nervous system. Moreover, it influences the enzyme isocitrate dehydrogenase and, more importantly, the resistance to standard treatment via various mechanisms, such as O6-methylguanine methyltransferase. This review summarizes the anticancer effects of resveratrol in various types of brain cancer. Several in vitro and in vivo studies have presented promising results; however, further clinical research is necessary to prove the therapeutic efficacy of resveratrol in brain cancer treatment.


2012 ◽  
Vol 2012 ◽  
pp. 1-9 ◽  
Author(s):  
Hitomi Kurose ◽  
Masa-Aki Shibata ◽  
Munekazu Iinuma ◽  
Yoshinori Otsuki

The development of molecularly targeted drugs has greatly advanced cancer therapy, despite these drugs being associated with some serious problems. Recently, increasing attention has been paid to the anticancer effects of natural products.α-Mangostin, a xanthone isolated from the pericarp of mangosteen fruit, has been shown to induce apoptosis in various cancer cell lines and to exhibit antitumor activity in a mouse mammary cancer model. In this study, we investigated the influence ofα-mangostin on apoptosis and cell cycle in the human breast cancer cell line MDA-MB231 (carrying a p53 mutation, and HER2, ER, and PgR negative) in order to elucidate its anticancer mechanisms. Inα-mangostin-treated cells, induction of mitochondria-mediated apoptosis was observed. On cell-cycle analysis, G1-phase arrest, increasedp21cip1expression and decreases in cyclins, cdc(s), CDKs and PCNA were observed. In conclusion,α-mangostin may be useful as a therapeutic agent for breast cancer carrying a p53 mutation and having HER2- and hormone receptor-negative subtypes.


PLoS ONE ◽  
2012 ◽  
Vol 7 (12) ◽  
pp. e52335 ◽  
Author(s):  
Stuart J. Smith ◽  
Martin Wilson ◽  
Jennifer H. Ward ◽  
Cheryl V. Rahman ◽  
Andrew C. Peet ◽  
...  

Oncotarget ◽  
2018 ◽  
Vol 9 (30) ◽  
pp. 21296-21312 ◽  
Author(s):  
Camila Ramalho Bonturi ◽  
Helena Motaln ◽  
Mariana Cristina Cabral Silva ◽  
Bruno Ramos Salu ◽  
Marlon Vilela de Brito ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document